The Government of Uruguay finally reached an agreement with Pfizer for the supply of 3.7 million doses of COVID-19 vaccines during 2022, it was announced Thursday in Montevideo.
Uruguay's Secretary to the Presidency Álvaro Delgado is to meet with the regional manager of the Pfizer laboratory to finalize the details for the purchase of COVID-19 vaccines with which the administration of President Luis Lacalle Pou hopes to lure more foreign tourists into the country for the Summer season.
Argentina will start on October 12 vaccinating children aged between 3 and 11 who have other underlying conditions against COVID-19. Local health authorities have chosen the Sinopharm drug for the campaign.
Argentine health authorities Tuesday announced the arrival into the country of around 100,000 doses of Pfizer COVID-19 vaccines, which will be used as the second shots of Sputnik V.
The multinational Pfizer-BioNTech consortium has reached a deal with Brazilian laboratories Eurofarma to produce its famous COVID-19 vaccine in the South American country, it was announced Thursday.
Brazilian health authorities Wednesday announced the third dose of a COVID-19 vaccine will begin to be distributed during the second half of September 2021, for people over 70 years of age who have completed their full treatment more than six months ago.
Uruguay's Public Health Ministry (MSP) Tuesday announced 70% of the population had already received two doses of COVID-19 vaccines such as CoronaVac, Pfizer or AstraZeneca, while a private survey showed only 26.83% of Brazilians were at the same level.
United States health authorities Monday gave full approval to the COVID-19 vaccine developed by Pfizer-BioNTech, which will now be marketed under the Comirnaty brand. Moderna's drug is expected to be approved shortly.
Rio de Janeiro city officials have reported a local man was able to get vaccinated five times in ten weeks against covid-19, presumably thanks to failures in the electronic documenting system.
Uruguayan President Luis Lacalle Pou Thursday said the potential need for a third dose of an anticovid-19 vaccine was still under study but should the experts find it necessary it would be with the one produced by Pfizer.